The sodium-glucose cotransporter 2 inhibitor luseogliflozin can suppress muscle atrophy in Db/Db mice by suppressing the expression of <i>foxo1</i>Takuro Okamura, Michiaki Fukui|Journal of Clinical Biochemistry and Nutrition|2019Cited by 28